Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2003
07/02/2003EP1322332A2 Compositions and methods for inhibition of hiv-1 infection
07/02/2003EP1322328A2 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
07/02/2003EP1322319A1 Use of il-8 protein modulators in the treatment of viral infections
07/02/2003EP1043959A4 Interactive dental restorative network
07/02/2003EP0900025B1 Moraxella catarrhalis outer membrane protein omp106, gene sequence and uses thereof
07/02/2003EP0731845B1 Homologous recombination antibody expression system for murine cells
07/02/2003CN1427892A Virulence genes, proteins and their use
07/02/2003CN1427891A Anti-EGFRvIII scFv with improved cytotoxi city and yield, immunotoxins based thereon, and methods of use thereof
07/01/2003US6586656 Transgenic rodents harboring APP allele having Swedish mutation
07/01/2003US6586583 Recombinant DNA molecule comprising regulatory sequence in combination with a heterologous plant promoter and structural gene; use in pulp and paper bleaching, waste destruction, soil remediation, organic synthesis
07/01/2003US6586578 Deformylase (def1); isolated polynucleotide of given sequence; detects Staphylococcus aureus; can use to screen for antibiotics
07/01/2003US6586571 Isolated polypeptide that binds to MORT-1 (mediators of receptor toxicity) protein
07/01/2003US6586569 Endometriosis-associated gene
07/01/2003US6586568 Purified viral polypeptide comprising amino acid sequence encoded by positive stranded RNA genome which comprises an open reading frame encoding a polyprotein; use in diagnosing and providing safer blood and organ supply
07/01/2003US6586397 Polypeptides encoding tyrosine kinase containing immunoglobulin and endithelial growth factor homology domains; induce vascularization
07/01/2003US6586395 Apoptosis-modulating proteins
07/01/2003US6586394 Tissue-derived tumor growth inhibitor
07/01/2003US6586392 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins
07/01/2003US6586242 TAO protein kinases and methods of use therefor
07/01/2003US6586236 Modulation of polypeptide display on modified filamentous phage use
07/01/2003US6586222 Recombinant PR-3 and compositions thereof
07/01/2003US6586192 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
07/01/2003US6586191 Isolated nucleic acids encoding mammalian galanin receptors, isolated galanin receptor proteins, vectors comprising isolated nucleic acid encoding a mammalian galanin receptor, cells comprising such vectors, antibodies directed to a
07/01/2003US6586185 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances
07/01/2003US6586182 Selecting amino acid sequence variations based on computer modeling; polynucleotides comprising subsequences of nucleic acids encoding the amino acid variations; reassembling into nucleotide sequences encoding mutagenized polypeptides
07/01/2003US6586179 Human Eag2
07/01/2003US6585973 Solid phase adjuvant methodology is used to synthesize a hapten-protein-polysaccharide conjugate vaccines to stimulate an anti- polysaccharide antibody response in infants who are otherwise unable to respond to polysaccharide alone
07/01/2003CA2123303C Icams immunoglobulin constant region soluble fusion proteins
07/01/2003CA2122338C Novel human cdc25 genes, encoded products and uses therefor
07/01/2003CA2080548C Monoclonal antibodies to hepatitis c virus
07/01/2003CA2067469C Recombinant vaccine against marek's disease
07/01/2003CA2046917C Polypeptides having thyrotropin-receptor activity, nucleic acid sequences coding for such receptors and polypeptides, and applications of these polypeptides
06/2003
06/26/2003WO2003052416A2 Focussed antibody technology
06/26/2003WO2003052102A1 Specific antibody for detecting bradeion
06/26/2003WO2003052082A2 Fusion partner cells and uses thereof
06/26/2003WO2003052078A2 Insect g protein-coupled receptor genes and uses thereof
06/26/2003WO2003052050A2 P450 enzymes, nucleic acids encoding them and methods of making and using them
06/26/2003WO2003052048A2 Nucleic acid-associated proteins
06/26/2003WO2003051928A1 Antibody specific for detection of bradeion
06/26/2003WO2003051927A2 Production of f(ab')2 fragments in mammalian cells
06/26/2003WO2003051926A2 Anti-cd7 immunotoxin as fusion protein
06/26/2003WO2003051923A2 Novel g-protein coupled receptors and dna sequences thereof
06/26/2003WO2003051910A2 Inhibitors of hepatitis c virus protease
06/26/2003WO2003051720A2 A myeloma cell line useful for manufacturing recombinant proteins in chemically defined media
06/26/2003WO2003051311A2 Antibody inhibiting stem cell factor activity and use for treatment of asthma
06/26/2003WO2003051290A2 Treating b-cell mediated diseases by modulating dr6 activity
06/26/2003WO2003035678A3 Sperm factor sequences
06/26/2003WO2003024989A3 Activation and expansion of cells
06/26/2003WO2003014153A8 Cellular virus receptors and methods of use.
06/26/2003WO2003004636A3 Expression vectors encoding bacteriophage signal peptides
06/26/2003WO2003000721A3 Mycobacterial antigens expressed under low oxygen tension
06/26/2003WO2002102855A3 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
06/26/2003WO2002093128A3 Identifying insulin response modulators and therapeutic uses thereof
06/26/2003WO2002070696A3 Cd109 nucleic acid molecules polypeptides and methods of use
06/26/2003WO2002064766A3 Bax-responsive genes for drug target identification in yeast and fungi
06/26/2003WO2002060953A3 Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer
06/26/2003WO2002055738A3 Molecules for disease detection and treatment
06/26/2003WO2002046385A3 Enzymes
06/26/2003WO2002044406A3 Projection against mycobacterial infections
06/26/2003WO2002016597A3 Lipid metabolism enzymes
06/26/2003US20030121073 Use of acetoacetyl-CoA thiolase for identifying new fungicidally active substances
06/26/2003US20030120059 Cell surface molecule-induced macrophage activation
06/26/2003US20030120058 Polypeptides; proteolysis splitting; antitumor agents
06/26/2003US20030120053 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030120052 Human genetic engineering; cancer diagnosis; hybrid nucleic acid
06/26/2003US20030120044 Methods of optimizing antibody variable region binding affinity
06/26/2003US20030120043 Tumor necrosis factor receptor-associated factors
06/26/2003US20030119715 Prevent retinoid binding; antiaging agents; activation cell differentiation
06/26/2003US20030119185 Activation and expansion of cells
06/26/2003US20030119168 Diagnosis of anticancer agents using nucleic acids
06/26/2003US20030119146 Novel nucleic acids and polypeptides which resemble Rho and which interact with cell signalling pathways and proteins
06/26/2003US20030119116 Fusion proteins; binding to antibodies
06/26/2003US20030119111 G-protein coupled receptor, named 2871 receptor
06/26/2003US20030119110 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119106 Fusion proteins; binding to antibodies
06/26/2003US20030119103 Fusion proteins; binding to antibodies
06/26/2003US20030119101 Bactericides, fungicides; transporter proteins
06/26/2003US20030119097 Anticancer agents; screening genetic engineered libraries
06/26/2003US20030119096 Detect, calibration binding of galanin; therapy for nervous system disorders
06/26/2003US20030119095 Novel nucleic acid sequences encoding human vesicle transport protein-like and residue rat-like polypeptides
06/26/2003US20030119083 Generating antibodies; binding antigen; therapy for drug overdose
06/26/2003US20030119082 Fluorescence immunoassay
06/26/2003US20030119079 Using autoantibodies; vaccines
06/26/2003US20030119078 Method of reducing immunogenicity of toxicity of an antibody of IgG class
06/26/2003US20030119076 B7-like polynucleotides, polypeptides, and antibodies
06/26/2003US20030119075 Anti-tissue factor antibodies with enhanced anticoagulant potency
06/26/2003US20030119071 Tetrameric antibody complexes for blocking non-specific labeling of antigens
06/26/2003US20030119070 Complexing ligand, peptide ; displacement of one ligand with another
06/26/2003US20030119058 Method of assaying type III collagen degradation
06/26/2003US20030119056 Focused libraries of genetic packages
06/26/2003US20030119055 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119045 Controlling cell proliferation; adjust adhesion to substrate
06/26/2003US20030119039 Detection using antibodies
06/26/2003US20030119033 Immunoassay using antibodies
06/26/2003US20030119018 Novel polynucleotides
06/26/2003US20030119013 Identification of essential genes of Aspergillus fumigatus and methods of use
06/26/2003US20030119001 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030118990 Novel estrogen-regulated G protein gamma subunit: compositions and methods of use
06/26/2003US20030118988 Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof
06/26/2003US20030118985 Immunoassay using label; medical diagnosis